Polysialylation controls dendritic cell trafficking by regulating chemokine recognition

Science

Volumn 351, Issue 6269, 2016, Pages 186-190

  Kiermaier, Eva ^a   Moussion, Christine ^a   Veldkamp, Christopher T ^b,c   Gerardy Schahn, Rita ^d   De Vries, Ingrid ^a   Williams, Larry G ^b   Chaffee, Gary R ^b   Phillips, Andrew J ^b   Freiberger, Friedrich ^d   Imre, Richard ^e   Taleski, Deni ^f   Payne, Richard J ^f   Braun, Asolina ^d   Förster, Reinhold ^d   Mechtler, Karl ^e   Mühlenhoff, Martina ^d   Volkman, Brian F ^c   Sixt, Michael ^a  

^a INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA   (Austria)

^b UNIVERSITY OF WISCONSIN WHITEWATER   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CCR7 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR7; LIGAND; POLYSIALIC ACID; SECONDARY LYMPHOID TISSUE CHEMOKINE; SIALIC ACID DERIVATIVE;

CELLS AND CELL COMPONENTS; CHEMICAL REACTION; HOMEOSTASIS; LIGAND; NERVOUS SYSTEM; PROTEIN;

ARTICLE; CELL MIGRATION; DENDRITIC CELL; GLYCOSYLATION; HUMAN; INFLAMMATION; LYMPH NODE; LYMPH VESSEL; NONHUMAN; PRIORITY JOURNAL; SIALYLATION; STIMULUS RESPONSE; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CHEMOTAXIS; CYTOLOGY; METABOLISM; MOUSE; MUTANT MOUSE STRAIN; PHYSIOLOGY; PROTEIN PROCESSING;

MUS;

ANIMALS; BONE MARROW CELLS; CHEMOKINE CCL21; CHEMOTAXIS; DENDRITIC CELLS; GLYCOSYLATION; LIGANDS; LYMPH NODES; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, CCR7; SIALIC ACIDS;

EID: 84955091858     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aad0512     Document Type: Article

References (23)

1. U. Rutishauser, Nat. Rev. Neurosci. 9, 26-35 (2008).
2. M. Mühlenhoff, M. Rollenhagen, S. Werneburg, R. Gerardy-Schahn, H. Hildebrandt, Neurochem. Res. 38, 1134-1143 (2013).
3. R. L. Schnaar, R. Gerardy-Schahn, H. Hildebrandt, Physiol. Rev. 94, 461-518 (2014).
4. R. A. Falconer, R. J. Errington, S. D. Shnyder, P. J. Smith, L. H. Patterson, Curr. Cancer Drug Targets 12, 925-939 (2012).
5. A. Harduin-Lepers et al., Front. Biosci. (Elite Ed.) 4, 499-515 (2012).
6. Y. M. J. Al-Saraireh et al., PLOS ONE 8, e73366 (2013).
7. S. Curreli, Z. Arany, R. Gerardy-Schahn, D. Mann, N. M. Stamatos, J. Biol. Chem. 282, 30346-30356 (2007).
8. A. Rey-Gallardo et al., Glycobiology 20, 1139-1146 (2010).
9. M. Bax, S. J. van Vliet, M. Litjens, J. J. García-Vallejo, Y. van Kooyk, PLOS ONE 4, e6987 (2009).
10. P. M. Drake et al., J. Immunol. 181, 6850-6858 (2008).
11. M. Eckhardt et al., J. Neurosci. 20, 5234-5244 (2000).
12. C. Moussion, J.-P. Girard, Nature 479, 542-546 (2011).
13. M. Wendland et al., Immunity 35, 945-957 (2011).
14. S. E. Macatonia, S. C. Knight, A. J. Edwards, S. Griffiths, P. Fryer, J. Exp. Med. 166, 1654-1667 (1987).
15. R. Förster et al., Cell 99, 23-33 (1999).
16. A. Braun et al., Nat. Immunol. 12, 879-887 (2011).
17. M. Weber et al., Science 339, 328-332 (2013).
18. A. Link et al., Nat. Immunol. 8, 1255-1265 (2007).
19. C. T. Veldkamp et al., Biochemistry 54, 4163-4166 (2015).
20. M. Love et al., Biochemistry 51, 733-735 (2012).
21. J. Hirose, H. Kawashima, O. Yoshie, K. Tashiro, M. Miyasaka, J. Biol. Chem. 276, 5228-5234 (2001).
22. A. Rey-Gallardo, C. Delgado-Martín, R. Gerardy-Schahn, J. L. Rodríguez-Fernández, M. A. Vega, Glycobiology 21, 655-662 (2011).
23. M. Rollenhagen et al., J. Biol. Chem. 288, 22880-22892 (2013).